Prenetics Global Limited Class A Ordinary Share (PRE) Stock Price

PREStock

$25.76+248.11%52W

Market Cap$432.24M

P/E—

PEG Ratio—

Div yield—

Beta0.31

PRE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)50.08%

Price vs S&P 500 (4W)37.55%

VGM Score57.76

Book Value / Share (Quarterly)$7.85

P/TBV (Annual)1.42x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-30.56%

Cash Flow / Share (Quarterly)$-0.79

Price vs S&P 500 (YTD)50.73%

Gross Margin (TTM)62.81%

Net Profit Margin (TTM)-42.21%

EPS (TTM)$-3.30

10-Day Avg Trading Volume0.41M

EPS Excl Extra (TTM)$-3.30

Revenue Growth (5Y)58.62%

EPS (Annual)$-2.68

ROI (Annual)-23.83%

Gross Margin (Annual)53.54%

Net Profit Margin (5Y Avg)-92.87%

Cash / Share (Quarterly)$6.88

Revenue Growth QoQ (YoY)-89.62%

ROA (Last FY)-18.30%

Revenue Growth TTM (YoY)-77.95%

EBITD / Share (TTM)$-0.51

ROE (5Y Avg)-33.63%

Operating Margin (TTM)-39.66%

Cash Flow / Share (Annual)$-6.78

P/B Ratio2.79x

P/B Ratio (Quarterly)2.25x

Net Income / Employee (Annual)$-132,300

EV / Revenue (TTM)3.89x

Net Interest Coverage (TTM)-98.76x

ROA (TTM)-25.96%

EPS Incl Extra (Annual)$-2.68

Current Ratio (Annual)2.97x

Quick Ratio (Quarterly)4.60x

3-Month Avg Trading Volume0.24M

52-Week Price Return248.11%

Revenue / Employee (TTM)$254,400

Tangible BV / Share (Quarterly)$5.60

P/S Ratio (Annual)3.66x

Asset Turnover (Annual)0.45x

52-Week High$26.50

Operating Margin (5Y Avg)-54.23%

EPS Excl Extra (Annual)$-2.68

CapEx CAGR (5Y)77.92%

26-Week Price Return62.01%

Quick Ratio (Annual)2.37x

13-Week Price Return27.65%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)5.15x

Enterprise Value$282.17M

Revenue / Share Growth (5Y)39.53%

Asset Turnover (TTM)0.38x

Revenue / Employee (Annual)$324,200

Inventory Turnover (Annual)6.31x

Pretax Margin (Annual)-39.20%

Cash / Share (Annual)$5.62

3-Month Return Std Dev86.83%

Gross Margin (5Y Avg)37.09%

Net Income / Employee (TTM)$-176,900

ROE (Last FY)-24.10%

Net Interest Coverage (Annual)-28.25x

EPS Basic Excl Extra (Annual)$-2.68

Receivables Turnover (TTM)20.74x

EV / Free Cash Flow (TTM)35.49x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-3.30

Receivables Turnover (Annual)22.48x

ROI (TTM)-33.80%

P/S Ratio (TTM)4.66x

Pretax Margin (5Y Avg)-74.18%

Revenue / Share (Annual)$6.57

Tangible BV / Share (Annual)$13.89

Price vs S&P 500 (52W)229.55%

Year-to-Date Return63.56%

5-Day Price Return18.06%

EPS Normalized (Annual)$-2.68

ROA (5Y Avg)-48.57%

Net Profit Margin (Annual)-40.82%

Month-to-Date Return38.20%

Cash Flow / Share (TTM)$-2.78

EBITD / Share (Annual)$-3.01

Operating Margin (Annual)-48.14%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)20.57x

ROI (5Y Avg)-32.46%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-3.30

P/TBV (Quarterly)3.16x

P/B Ratio (Annual)1.42x

Inventory Turnover (TTM)4.51x

Pretax Margin (TTM)-50.98%

Book Value / Share (Annual)$13.89

Price vs S&P 500 (13W)25.70%

Beta0.31x

P/FCF (Annual)41.34x

Revenue / Share (TTM)$4.27

ROE (TTM)-34.19%

52-Week Low$7.27

vGradeC

gGradeD

mGradeA

vgmGradeC

PRE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 18, 2026	-$0.48	-$0.52	-8.33%(-$0.04)
Q1 2026	Jun 10, 2026	-$0.78	-$1.36	-75.48%(-$0.59)
Q4 2025	Feb 18, 2026	-$0.52	-$0.19	+63.18%(+$0.33)
Q3 2025	Nov 10, 2025	-$0.55	-$0.53	+3.64%(+$0.02)
Q2 2025	Sep 12, 2025	-$0.71	-$0.94	-32.39%(-$0.23)

PRE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$25.76
AAgilent Technologies Inc.	D	C	B	$153.84
WATWaters Corp	D	C	B	$414.69
ILMNIllumina Inc	D	D	A	$215.59
MTDMettler-Toledo International	D	C	B	$1398.58
RVTYRevvity, Inc.	C	D	A	$128.80
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$387.70
AVTRAvantor, Inc.	B	F	A	$14.58
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
BRKRBruker Corporation	D	D	B	$57.08
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$61.54
ALMRAlamar Biosciences, Inc. Common Stock	—	—	B	$30.71
CTKBCytek Biosciences, Inc. Common Stock	C	C	B	$4.68
MASS908 Devices Inc. Common Stock	C	C	B	$10.73
PACBPacific Biosciences of California, Inc.	D	C	C	$1.40
EYPTEyePoint, Inc. Common Stock	D	F	F	$4.48
LABStandard BioTools Inc. Common Stock	A	F	D	$0.64
QTRXQuanterix Corporation Common Stock	A	C	D	$2.64
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.89
SEERSeer, Inc. Class A Common Stock	C	D	C	$1.98
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.57
PRPOPrecipio, Inc. Common Stock	C	A	B	$28.85
HBIOHarvard Bioscience Inc	B	F	A	$7.93
ASTCAstrotech Corporation (DE) Common Stock	C	C	C	$7.15
BNGOBionano Genomics, Inc. Common Stock	A	C	D	$1.17
HLTHTema Healthcare AI ETF	—	F	F	$28.54
PRENWPrenetics Global Limited Warrant	—	—	F	$0.01

About Prenetics Global Limited Class A Ordinary Share

Prenetics Global Ltd is a diversified health sciences company operating three consumer healthcare brands: IM8 (a fast-growing supplement brand), Europa (sports distribution in the USA), and CircleDNA (direct-to-consumer DNA testing). The company has established a Bitcoin treasury with an initial approximately $20 million investment and a board-approved comprehensive digital asset strategy, positioning itself at the intersection of healthcare innovation and digital assets.